Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in

See also
Status	Clinical Trial	Phase
Completed	`NCT03459521` - Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.	N/A
Completed	`NCT02060162` - Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa
Completed	`NCT00912847` - Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma	N/A
Completed	`NCT04072211` - Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi District	Phase 4
Completed	`NCT01204762` - Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e Antigen	Phase 2
Completed	`NCT00805675` - Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB	Phase 3
Completed	`NCT02785835` - Hepatocellular Carcinoma in HIV-infected Patients
Completed	`NCT03083821` - A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting	Phase 1
Recruiting	`NCT01083251` - The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection	N/A
Not yet recruiting	`NCT05752890` - A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma
Recruiting	`NCT04231565` - Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.	N/A
Terminated	`NCT00678587` - Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures	Phase 3
Completed	`NCT00739752` - Interventions to Increase HBV Vaccinations in Sexually Transmitted Disease (STD) Clinics	N/A
Completed	`NCT03294798` - Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient	Phase 1/Phase 2
Withdrawn	`NCT04385524` - Use of Dynavax Heplisav B in Healthcare Workers Previously Vaccinated With 3-dose Vaccine Who Failed to Demonstrate Seroprotection	N/A
Enrolling by invitation	`NCT00663182` - Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis	Phase 4
Completed	`NCT00769730` - Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication	N/A
Completed	`NCT01438424` - Safety and Antiviral Activity of Entecavir in Participants With Chronic Hepatitis B Following Monotherapy in Other Entecavir Trials	Phase 2
Withdrawn	`NCT04046107` - Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy	Phase 1/Phase 2
Completed	`NCT05406089` - Effects of Antiviral Therapy on Patients With HBV-related HCC

NCT number	NCT02296853
Study type	Interventional
Source	Gilead Sciences
Contact
Status	Completed
Phase	Phase 1
Start date	December 22, 2014
Completion date	April 17, 2015

Study to Evaluate the Pharmacokinetics of Tenofovir Alafenamide (TAF) in Adults With Normal Hepatic Function and Adults With Severe Hepatic Impairment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms